Paper Details

  1. Home
  2. Paper Details

Long-term combined rIFN-alpha-2a and zidovudine therapy for HIV-associated Kaposi's sarcoma: clinical consequences and side effects.

Author: BratzkeB, OrfanosC E, SchaartF, StadlerR

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Combination therapy of interferon alpha (IFN-alpha) and zidovudine (AZT) was found to be effective in controlling HIV-related Kaposi's sarcoma in more than 40% of patients. In a study of 21 homosexual men with histologically proven HIV-associated KS, complete remission was observed in 4 patients, partial remission in 3, stable disease in 2, and progression in 6. Negative p24 expression prior to treatment was a positive predictor of response.
Paper Details　
Original Abstract of the Article :
Interferon alpha (IFN-alpha) has been shown to be effective in treating HIV-associated KS in at least 30% of patients, and Zidovudine has proved beneficial for AIDS patients. Moreover, both drugs have demonstrated an inhibitory effect on HIV replication. Based on the above, we combined IFN-alpha and...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/1523-1747.ep12875494

データ提供：米国国立医学図書館（NLM）

Combating HIV-Associated Kaposi's Sarcoma

HIV-associated Kaposi's sarcoma (KS) is a serious complication of HIV infection, often leading to life-threatening conditions. This research explores the potential of combining interferon alpha (IFN-alpha) and zidovudine (AZT) in treating HIV-associated KS. The study investigates the clinical consequences and side effects of this combination therapy, highlighting its effectiveness in controlling KS progression in a significant portion of patients. The authors conclude that this combination therapy might offer a viable treatment option for HIV-associated KS, particularly for patients with severely compromised immune systems.

A Collaborative Approach to Combating KS

This research underscores the importance of a multifaceted approach to treating HIV-associated KS. The study's findings suggest that combining IFN-alpha and AZT might offer a more effective treatment strategy for managing KS progression in a broader range of patients. It's a reminder that a collaborative effort, like a caravan traversing the desert, is needed to combat the challenges of HIV infection and its associated complications.

Hope on the Horizon

This research offers hope for individuals living with HIV and facing the challenges of KS. Imagine a world where KS is no longer a life-threatening complication of HIV. This research provides a potential path towards a future where KS is effectively managed, enabling individuals with HIV to live longer, healthier lives.

Dr. Camel's Conclusion

This research provides a valuable insight into the potential of combination therapy in combating HIV-associated KS. The findings suggest that combining IFN-alpha and AZT might offer a more effective and comprehensive approach to managing this complex condition. Like a camel using its keen senses to navigate the desert, this research offers a new perspective for navigating the challenges of HIV-associated KS, potentially leading to better outcomes for patients.

Date :
  1. Date Completed 1991-01-29
  2. Date Revised 2019-07-23
Further Info :

Pubmed ID

2258633

DOI: Digital Object Identifier

10.1111/1523-1747.ep12875494

Related Literature

Article Analysis
・Side Effects of zidovudine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.